Chikungunya differential diagnosis: Difference between revisions

Jump to navigation Jump to search
Line 21: Line 21:
! style="background: #4479BA; width: 400px;" | {{fontcolor|#FFF|Presentation}}
! style="background: #4479BA; width: 400px;" | {{fontcolor|#FFF|Presentation}}
|-
|-
| style="padding: 5px 5px; background: #DCDCDC;" | '''Malaria'''
| style="padding: 5px 5px; background: #DCDCDC;" | '''[[Malaria]]'''
| style="padding: 5px 5px; background: #DCDCDC;" | Periodicity of fever and alteration of consciousness
| style="padding: 5px 5px; background: #DCDCDC;" | Periodicity of [[fever]] and [[alteration of consciousness]]
|-
|-
| style="padding: 5px 5px; background: #DCDCDC;" | '''Dengue Fever'''
| style="padding: 5px 5px; background: #DCDCDC;" | '''[[Dengue Fever]]'''
| style="padding: 5px 5px; background: #DCDCDC;" | Fever and two or more of the following, retro-orbital or ocular pain, headache,rash, myalgia, arthralgia, leucopenia, or hemorrhagic manifestations.  
| style="padding: 5px 5px; background: #DCDCDC;" | [[Fever]] and two or more of the following, retro-orbital or ocular pain, [[headache]], [[rash]], [[myalgia]], [[arthralgia]], [[leucopenia]], or [[hemorrhage|hemorrhagic]] manifestations.  
|-
|-
| style="padding: 5px 5px; background: #DCDCDC;" |'''Leptospirosis'''
| style="padding: 5px 5px; background: #DCDCDC;" |'''[[Leptospirosis]]'''
| style="padding: 5px 5px; background: #DCDCDC;" |Severe myalgia localized to calf muscles with conjunctival congestion/or subconjunctival hemorrhage with or without jaundice or oliguria. Consider history of contact with contaminated water
| style="padding: 5px 5px; background: #DCDCDC;" |Severe [[myalgia]] localized to [[calf]] muscles with [[conjunctival congestion]]/or [[subconjunctival hemorrhage]] with or without [[jaundice]] or [[oliguria]]. Consider history of contact with contaminated water
|-
|-
| style="padding: 5px 5px; background: #DCDCDC;" | '''Alphaviral infections (Mayaro, Ross River, Barmah Forest, O’nyong nyong, and Sindbis viruses)'''
| style="padding: 5px 5px; background: #DCDCDC;" | '''[[alphavirus|Alphaviral infections]] (Mayaro, Ross River, Barmah Forest, O’nyong nyong, and Sindbis viruses)'''
| style="padding: 5px 5px; background: #DCDCDC;" | Similar clinical presentation as Chikunguyna; inquire about travel history and known areas of Mayaro in the Americas
| style="padding: 5px 5px; background: #DCDCDC;" | Similar clinical presentation as Chikunguyna; inquire about travel history and known areas of Mayaro in the Americas
|-
|-
| style="padding: 5px 5px; background: #DCDCDC;" | '''Post-infectious arthritis (including rheumatic fever)'''
| style="padding: 5px 5px; background: #DCDCDC;" | '''Post-infectious arthritis (including rheumatic fever)'''
| style="padding: 5px 5px; background: #DCDCDC;" | Arthritis of one or more, typically larger joints due to an infectious disease such as Chlamydia, shigella, and gonorrhea.  Rheumatic fever is seen more commonly in children as migratory polyarthritis predominantly affecting large joints.  Consider antistreptolysin O (ASO) titer and history of sore throat with Jones criteria for rheumatic fever
| style="padding: 5px 5px; background: #DCDCDC;" | [[Arthritis]] of one or more, typically larger [[joints]] due to an infectious disease such as [[Chlamydia]], [[Shigella]], and [[gonorrhea]][[Rheumatic fever]] is seen more commonly in children as [[migratory polyarthritis]] predominantly affecting large joints.  Consider [[antistreptolysin O]] ([[ASO]]) titer and history of [[sore throat]] with [[Jones criteria]] for [[rheumatic fever]].
|-
|-
| style="padding: 5px 5px; background: #DCDCDC;" | '''Juvenile rheumatoid arthritis'''
| style="padding: 5px 5px; background: #DCDCDC;" | '''[[Juvenile rheumatoid arthritis]]'''
| style="padding: 5px 5px; background: #DCDCDC;" | Abrupt onset of fever and subsequent joint involvement in children
| style="padding: 5px 5px; background: #DCDCDC;" | Abrupt onset of [[fever]] and subsequent [[joint]] involvement in children
|-
|-
| style="padding: 5px 5px; background: #FFF;" colspan="2"| <SMALL>Table adapted from ''Preparedness and Response for Chikungunya Virus: Introduction in the Americas. PAHO © 2011.''<ref name=PAHO2011>{{cite book | last = | first = | title = Preparedness and response for Chikungunya virus introduction in the Americas | publisher = Pan American Health Organization CDC, Center for Disease Control and Prevention | location = Washington, DC | year = 2011 | isbn = 978-92-75-11632-6 }}</ref></SMALL>
| style="padding: 5px 5px; background: #FFF;" colspan="2"| <SMALL>Table adapted from ''Preparedness and Response for Chikungunya Virus: Introduction in the Americas. PAHO © 2011.''<ref name=PAHO2011>{{cite book | last = | first = | title = Preparedness and response for Chikungunya virus introduction in the Americas | publisher = Pan American Health Organization CDC, Center for Disease Control and Prevention | location = Washington, DC | year = 2011 | isbn = 978-92-75-11632-6 }}</ref></SMALL>

Revision as of 17:40, 15 June 2014

Chikungunya Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Chikungunya from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Primary Prevention

Future or Investigational Therapies

Case Studies

Case #1

Chikungunya differential diagnosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Chikungunya differential diagnosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Chikungunya differential diagnosis

CDC on Chikungunya differential diagnosis

Chikungunya differential diagnosis in the news

Blogs on Chikungunya differential diagnosis

Directions to Hospitals Treating Chikungunya

Risk calculators and risk factors for Chikungunya differential diagnosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Alejandro Lemor, M.D. [2], Alonso Alvarado, M.D. [3]

Overview

Chikunguyna must be differentiated from other diseases that present with flu like symptoms such as fever, headache, fatigue, joint aches or arthralgias, myalgias. Diseases with similar symptoms include dengue, influenza, measles, rubella, malaria, and yellow fever.

Differential Diagnosis


Disease Presentation
Malaria Periodicity of fever and alteration of consciousness
Dengue Fever Fever and two or more of the following, retro-orbital or ocular pain, headache, rash, myalgia, arthralgia, leucopenia, or hemorrhagic manifestations.
Leptospirosis Severe myalgia localized to calf muscles with conjunctival congestion/or subconjunctival hemorrhage with or without jaundice or oliguria. Consider history of contact with contaminated water
Alphaviral infections (Mayaro, Ross River, Barmah Forest, O’nyong nyong, and Sindbis viruses) Similar clinical presentation as Chikunguyna; inquire about travel history and known areas of Mayaro in the Americas
Post-infectious arthritis (including rheumatic fever) Arthritis of one or more, typically larger joints due to an infectious disease such as Chlamydia, Shigella, and gonorrhea. Rheumatic fever is seen more commonly in children as migratory polyarthritis predominantly affecting large joints. Consider antistreptolysin O (ASO) titer and history of sore throat with Jones criteria for rheumatic fever.
Juvenile rheumatoid arthritis Abrupt onset of fever and subsequent joint involvement in children
Table adapted from Preparedness and Response for Chikungunya Virus: Introduction in the Americas. PAHO © 2011.[1]

Comparison between Chikungunya and Dengue Fever Adapted from Clin Infect Dis. (2009) 49(6):942-948.[2]


Clinical and laboratory findings of chikunguyna and dengue fever
Clinical Findings Chikungunya Dengue Fever
Fever (>102°F or 39°C) +++ ++
Headache ++ ++
Rash ++ +
Arthralgias +++ +/–
Myalgias + ++
Shock +/–
Bleeding dyscrasias +/– ++
Laboratory Findings
Elevated hematocrit ++
Leukopenia ++ +++
Neutropenia + +++
Lymphopenia +++ ++
Thrombocytopenia + +++
Mean frequency of symptoms from studies where the two diseases were directly compared among patient seeking care; +++ = 70-100% of patients; ++ = 40-69%; + = 10-39%; +/– = <10%; — = 0%[3][4]

References

  1. Preparedness and response for Chikungunya virus introduction in the Americas. Washington, DC: Pan American Health Organization CDC, Center for Disease Control and Prevention. 2011. ISBN 978-92-75-11632-6.
  2. Staples, J. Erin; Breiman, Robert F.; Powers, Ann M. (2009). "Chikungunya Fever: An Epidemiological Review of a Re‐Emerging Infectious Disease". Clinical Infectious Diseases. 49 (6): 942–948. doi:10.1086/605496. ISSN 1058-4838.
  3. S. Nimmannitya, S. B. Halstead, S. N. Cohen & M. R. Margiotta (1969). "Dengue and chikungunya virus infection in man in Thailand, 1962-1964. I. Observations on hospitalized patients with hemorrhagic fever". The American journal of tropical medicine and hygiene. 18 (6): 954–971. PMID 5355242. Unknown parameter |month= ignored (help)
  4. Patrick Hochedez, Ana Canestri, Amelie Guihot, Segolene Brichler, Francois Bricaire & Eric Caumes (2008). "Management of travelers with fever and exanthema, notably dengue and chikungunya infections". The American journal of tropical medicine and hygiene. 78 (5): 710–713. PMID 18458301. Unknown parameter |month= ignored (help)

External Links